Research report

United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023

Format : Pdf

Publish Date: 18th May 2017

Pages: 140

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.

Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.
 
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.

Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.

The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023” examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market. 

The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market. 

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.


Key Topics Covered in the Report
 

United States Actual NIPT Test Volume & Market Revenue (2015 - 2023)
United States Potential NIPT Test Volume & Market Revenue (2015 - 2023)
United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
United States High Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
United States High Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
United States NIPT Test Market - Reimbursement & Regulation System
NIPT Test Implementation in High–Income Countries
United States NIPT Test Market - Comparative Test Analysis
United States NIPT Test Market – Major Deal Types
Key Companies Analysis
Key Drivers and Inhibitors of the United States NIPT Test Market

Key Companies Covered in the Report are as follows:

Sequenom Laboratories (LabCorp)
Ariosa Diagnostics (Roche)
Illumina
Natera
Quest Diagnostics

 

Research Methodology 
 

DPI Research’s team of researchers and analysts use a variety of research sources for making a report. Most of the data – information and statistics – for our products is gathered using the secondary research by our in–house team of researchers. The main objective of DPI Research’s secondary research exercise is to exhaust all sources of published information including websites of government agencies, consumer and trade associations, annual reports and accounts of companies, news articles from well–known publications and online databases. The data thus gathered is send to our team of analysts who verify that data and look for research gaps. These gaps are filled through primary research, that is, our analysts gain information from various agencies, associations and companies using customer surveys, telephonic and email interviews, etc. Finally, all the information collected using secondary and primary research is analysed and synthesized by our analysts and is presented in a report. 

Industry information and data for this report has been sourced through numerous channels including publicly available information from companies’ and industry association websites. For industry sizing, segmentation and trends, apart from desk research, we have contacted industry experts and executives from various companies. 

Market forecasts are done using statistical forecasting techniques based on historic performance. Statistical tools are further supplemented with qualitative parameters like industry expectation, economic drivers, new product development, customer surveys, ongoing research, etc. 

All the information gathered was then analysed and synthesized by our in–house team of analysts. 

1. Executive Summary

2. United States Non–Invasive Prenatal Testing(NIPT) Market Analysis (2015 – 2023) 
 
2.1 Overall Actual NIPT Test Volume & Forecast
2.1.1 Average Risk Actual NIPT Test Volume & Forecast
2.1.2 High Risk Actual NIPT Test Volume & Forecast
 
2.2 Overall Potential NIPT Test Volume & Forecast
2.2.1 Average Risk Potential NIPT Test Volume & Forecast
2.2.2 High Risk Potential NIPT Test Volume & Forecast
 
2.3 Overall Actual NIPT Test Market Revenue & Forecast
2.3.1 Average Risk Actual NIPT Test Market Revenue & Forecast
2.3.2 High Risk Actual NIPT Test Market Revenue & Forecast
 
2.4 Overall Potential NIPT Test Market Revenue & Forecast
2.4.1 Average Risk Potential NIPT Test Market Revenue & Forecast
2.4.2 High Risk Potential NIPT Test Market Revenue & Forecast

3. Key Drivers and Inhibitors of the United States NIPT Test Market
 
3.1 Market Drivers
3.2 Inhibitors

4. United States NIPT Test Market: Reimbursement & Regulation System
 
4.1 Reimbursement System
4.2 Regulation System

5. Non–Invasive Prenatal Testing (NIPT) Implementation – High–Income Countries
 
5.1.1 Clinical Issues
5.1.2 Ethical Issues
5.1.3 Legal and Regulatory Issues

6. Competitive Landscape
 
6.1 Non–Invasive Prenatal Testing(NIPT) – Comparative Analysis
 
6.2 Non–Invasive Prenatal Testing – Collaboration Deals
 
6.2.1 Year 2007
6.2.2 Year 2013
6.2.3 Year 2014
6.2.4 Year 2015
6.2.5 Year 2016
6.2.6 Year 2017
 
6.3 Non–Invasive Prenatal Testing – Venture Capital Investment
 
6.3.1 Year 2011
6.3.2 Year 2012
6.3.3 Year 2013
6.3.4 Year 2015
 
6.4 Non–Invasive Prenatal Testing – Merger and Acquisition
 
6.4.1 Year 2013
6.4.2 Year 2014
6.4.3 Year 2016
 
6.5 Non–Invasive Prenatal Testing – Exclusive Agreement
 
6.5.1 Year 2008
6.5.2 Year 2013
6.5.3 Year 2014
6.5.4 Year 2015
6.5.5 Year 2016
 
6.6 Non–Invasive Prenatal Testing – Licensing Agreement
 
6.6.1 Year 2007
6.6.2 Year 2011
6.6.3 Year 2013
6.6.4 Year 2014
6.6.5 Year 2015
 
6.7 Non–Invasive Prenatal Testing – Distribution Agreement
 
6.7.1 Year 2012
6.7.2 Year 2013
6.7.3 Year 2014
 
6.8 Non–Invasive Prenatal Testing – Partnership Deals
 
6.8.1 Year 2013
6.8.2 Year 2014
6.8.3 Year 2015

7. Key Companies Analysis
 
7.1 Sequenom Laboratories (LabCorp) 
7.1.1 Business Overview
7.1.2 NIPT Test Portfolio
7.1.3 NIPT Test Analysis (Volume and Value) 
7.1.3.1 Overall NIPT Test Volume & Forecast
7.1.3.2 Overall NIPT Test Market Revenue & Forecast
7.1.4 Sequenom Diagnostics – International Distributors
7.1.5 NIPT Test - Latest Development & Trends
 
7.2 Ariosa Diagnostics (Roche) 
7.2.1 Business Overview
7.2.2 NIPT Test Portfolio
7.2.3 NIPT Test Analysis (Volume and Value)
7.2.3.1 Overall NIPT Test Volume & Forecast
7.2.3.2 Overall NIPT Test Market Revenue & Forecast
7.2.4 NIPT Test - Latest Development & Trends
 
7.3 Illumina
7.3.1 Business Overview
7.3.2 NIPT Test Portfolio
7.3.3 NIPT Test Analysis (Volume and Value) 
7.3.3.1 Overall NIPT Test Volume & Forecast
7.3.3.2 Overall NIPT Test Market Revenue & Forecast
7.3.4 NIPT Test - Latest Development & Trends
 
7.4 Natera
7.4.1 Business Overview
7.4.2 NIPT Test Portfolio
7.4.3 NIPT Test Analysis (Volume and Value) 
7.4.3.1 Overall NIPT Test Volume & Forecast
7.4.3.2 Overall NIPT Test Market Revenue & Forecast
7.4.4 NIPT Test - Latest Development & Trends
 
7.5 Quest Diagnostics
7.5.1 Business Overview
7.5.2 NIPT Test Portfolio
7.5.3 NIPT Test - Latest Development & Trends

List of Tables

Table 3 1: Maternal Age at Delivery and Risk of Down Syndrome
 
Table 4 1: NIPT Test CMS Price(US$),2017
 
Table 6 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 6 2: Non–Invasive Prenatal Testing – Collaboration Deals, 2007 – 2017
Table 6 3: Non–Invasive Prenatal Testing – Venture Capital Investment, 2011 – 2015
Table 6 4: Non–Invasive Prenatal Testing – Merger & Acquisition, 2013 – 2016
Table 6 5: Non–Invasive Prenatal Testing – Exclusive Agreement, 2008 – 2016
Table 6 6: Non–Invasive Prenatal Testing – Licensing Agreement, 2007 – 2015
Table 6 7: Non–Invasive Prenatal Testing – Distribution Agreement, 2012 – 2014
Table 6 8: Non–Invasive Prenatal Testing – Partnership Deals, 2013 – 2015

List of Figures

Figure 2 1: United States – Actual NIPT Test Volume(Thousand),2015 – 2016
Figure 2 2: United States – Forecast for Actual NIPT Test Volume(Thousand),2017 – 2023
Figure 2 3: United States – Average Risk Actual NIPT Test Volume(Thousand),2015 – 2016
Figure 2 4: United States – Forecast for Average Risk Actual NIPT Test Volume(Thousand),2017 – 2023
Figure 2 5: United States – High Risk Actual NIPT Test Volume(Thousand),2015 – 2016
Figure 2 6: United States – Forecast for High Risk Actual NIPT Test Volume(Thousand),2017 – 2023
Figure 2 7: United States – Potential NIPT Test Volume(Thousand),2015 – 2016
Figure 2 8: United States – Forecast for Potential NIPT Test Volume(Thousand),2017 – 2023
Figure 2 9: United States – Average Risk Potential NIPT Test Volume(Thousand),2015 – 2016
Figure 2 10: United States – Forecast for Average Risk Potential NIPT Test Volume(Thousand),2017 – 2023
Figure 2 11: United States – High Risk Potential NIPT Test Volume(Thousand),2015 – 2016
Figure 2 12: United States – Forecast for High Risk Potential NIPT Test Volume(Thousand),2017 – 2023
Figure 2 13: United States – Actual NIPT Test Market Revenue(Million US$),2015 – 2016
Figure 2 14: United States – Forecast for Actual NIPT Test Market Revenue(Million US$),2017 – 2023
Figure 2 15: United States – Average Risk Actual NIPT Test Market Revenue(Million US$),2015 – 2016
Figure 2 16: United States – Forecast for Average Risk Actual NIPT Test Market Revenue(Million US$),2017 – 2023
Figure 2 17: United States – High Risk Actual NIPT Test Market Revenue(Million US$),2015 – 2016
Figure 2 18: United States – Forecast for High Risk Actual NIPT Test Market Revenue(Million US$),2017 – 2023
Figure 2 19: United States – Potential NIPT Test Market Revenue (Million US$),2015 – 2016
Figure 2 20: United States – Forecast for Potential NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 2 21: United States – Average Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2016
Figure 2 22: United States – Forecast for Average Risk Potential NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 2 23: United States – High Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2016
Figure 2 24: United States – Forecast for High Risk Potential NIPT Test Market Revenue (Million US$),2017 – 2023
 
Figure 6 1: Sequenom – Overall NIPT Test Volume (Thousand), 2011 – 2016
Figure 6 2: Sequenom – Forecast for Overall NIPT Test Volume (Thousand), 2017 – 2023
Figure 6 3: Sequenom - Overall NIPT Test Market Revenue (Million US$),2011 – 2016
Figure 6 4: Sequenom – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 5: Ariosa Diagnostics – Overall NIPT Test Volume (Thousand), 2012 – 2016
Figure 6 6: Ariosa Diagnostics – Forecast for Overall NIPT Test Volume (Thousand), 2017 – 2023
Figure 6 7: Ariosa Diagnostics - Overall NIPT Test Market Revenue (Million US$),2011 – 2016
Figure 6 8: Ariosa Diagnostics – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 9: Illumina – Overall NIPT Test Volume (Thousand), 2012 – 2016
Figure 6 10: Illumina – Forecast for Overall NIPT Test Volume (Thousand), 2017 – 2023
Figure 6 11: Illumina - Overall NIPT Test Market Revenue (Million US$),2012 – 2016
Figure 6 12: Illumina – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 13: Natera – Overall NIPT Test Volume (Thousand), 2013 – 2016
Figure 6 14: Natera – Overall NIPT Test Volume (Thousand), 2013 – 2016
Figure 6 15: Natera - Overall NIPT Test Market Revenue (Million US$),2013 – 2016
Figure 6 16: Natera – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023